BioSpace News Archive

Business

Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $218.8 million and screened approximately 456,000 people with Cologuard during the quarter ended September 30, 2019

October 29, 2019
·
14 min read
BioMidwest

Exact Sciences Presents New Stool-Based Colorectal Cancer Screening Performance Data, Initiates Prospective Screening Study

Promising research from Exact Sciences Corp. and Mayo Clinic shows new methylation and protein markers detect colorectal cancer and advanced adenomas with high accuracy.

October 29, 2019
·
10 min read
Business

Accuray Reports Fiscal 2020 First Quarter Financial Results

Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the first quarter of fiscal 2020 ended September 30, 2019.

October 29, 2019
·
11 min read
Drug Development

Syros Presents New Preclinical Data on SY-5609, Its Highly Selective Oral CDK7 Inhibitor, at AACR-NCI-EORTC International Conference

Syros Pharmaceuticals, a leader in the development of medicines that control the expression of genes, today presented new preclinical data for SY-5609, its highly-selective and potent oral inhibitor of cyclin-dependent kinase 7 (CDK7).

October 29, 2019
·
6 min read
Business

Cardiovascular Systems, Inc. Reports Fiscal 2020 First-Quarter Financial Results

Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, reported financial results for its fiscal first quarter, ended September 30, 2019.

October 29, 2019
·
23 min read
Business

Xencor to Host Third Quarter 2019 Financial Results Webcast and Conference Call on November 5, 2019

Xencor, Inc. announced that it will release third quarter 2019 financial results after the market closes on Tuesday, November 5, 2019.

October 29, 2019
·
1 min read
Business

Seattle Genetics Reports Third Quarter 2019 Financial Results

Seattle Genetics, Inc. (Nasdaq:SGEN) today reported financial results for the third quarter and nine months ended September 30, 2019.

October 29, 2019
·
15 min read
Drug Development

ArQule Presents Recent Data on ARQ 751 at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

ArQule, Inc. (Nasdaq: ARQL), today announced new clinical and preclinical data demonstrating the potential of the company’s AKT inhibitor ARQ 751 in treating solid tumors characterized by mutations in the PI3K/AKT/mTOR pathway.

October 29, 2019
·
6 min read
Business

TRACON to Report Third Quarter 2019 Company Highlights and Financial Results on November 5, 2019

TRACON Pharmaceuticals (NASDAQ:TCON), announced today that it will report its third quarter 2019 financial and operating results after the close of U.S. financial markets on Tuesday, November 5, 2019.

October 29, 2019
·
1 min read
Business

Theravance Biopharma to Report Third Quarter 2019 Financial Results on November 5

Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma” or the “Company”) today announced that it will release financial results for the period ended September 30, 2019 and provide a business update after market close on Tuesday, November 5, 2019.

October 29, 2019
·
2 min read